Opus Genetics Inc (IRD)
1.065
-0.02
(-2.29%)
USD |
NASDAQ |
Nov 14, 16:00
1.11
+0.04
(+4.23%)
After-Hours: 19:52
Opus Genetics Total Assets (Quarterly): 44.83M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 44.83M |
| March 31, 2024 | 51.84M |
| December 31, 2023 | 53.95M |
| September 30, 2023 | 54.19M |
| June 30, 2023 | 43.46M |
| March 31, 2023 | 45.40M |
| December 31, 2022 | 48.99M |
| September 30, 2022 | 14.57M |
| Date | Value |
|---|---|
| June 30, 2022 | 17.90M |
| March 31, 2022 | 20.48M |
| December 31, 2021 | 26.08M |
| September 30, 2021 | 23.20M |
| June 30, 2021 | 25.25M |
| March 31, 2021 | 12.13M |
| December 31, 2020 | 17.68M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
12.13M
Minimum
Mar 2021
54.19M
Maximum
Sep 2023
33.33M
Average
26.08M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Baxter International Inc | 26.31B |
| Syros Pharmaceuticals Inc | 85.00M |
| Elanco Animal Health Inc | 13.28B |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.198M |
| Shareholders Equity (Quarterly) | 40.64M |
| Current Ratio | 10.68 |